Logo image of ALMKT.PA

MAUNA KEA TECHNOLOGIES (ALMKT.PA) Stock Fundamental Analysis

EPA:ALMKT - FR0010609263 - Common Stock

0.106 EUR
+0 (+1.73%)
Last: 9/3/2025, 7:00:00 PM
Fundamental Rating

2

Overall ALMKT gets a fundamental rating of 2 out of 10. We evaluated ALMKT against 57 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ALMKT have multiple concerns. ALMKT is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year ALMKT has reported negative net income.
ALMKT had a negative operating cash flow in the past year.
In the past 5 years ALMKT always reported negative net income.
In the past 5 years ALMKT always reported negative operating cash flow.
ALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFALMKT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5M -10M -15M

1.2 Ratios

Looking at the Return On Assets, with a value of -64.04%, ALMKT is doing worse than 89.47% of the companies in the same industry.
Industry RankSector Rank
ROA -64.04%
ROE N/A
ROIC N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALMKT.PA Yearly ROA, ROE, ROICALMKT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

Looking at the Gross Margin, with a value of 31.67%, ALMKT is doing worse than 80.70% of the companies in the same industry.
In the last couple of years the Gross Margin of ALMKT has grown nicely.
The Profit Margin and Operating Margin are not available for ALMKT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
ALMKT.PA Yearly Profit, Operating, Gross MarginsALMKT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150 -200

More info and screens

0

2. Health

2.1 Basic Checks

ALMKT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ALMKT has more shares outstanding
The number of shares outstanding for ALMKT has been increased compared to 5 years ago.
The debt/assets ratio for ALMKT is higher compared to a year ago.
ALMKT.PA Yearly Shares OutstandingALMKT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ALMKT.PA Yearly Total Debt VS Total AssetsALMKT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.2 Solvency

Based on the Altman-Z score of -5.57, we must say that ALMKT is in the distress zone and has some risk of bankruptcy.
ALMKT has a worse Altman-Z score (-5.57) than 84.21% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -5.57
ROIC/WACCN/A
WACC6.07%
ALMKT.PA Yearly LT Debt VS Equity VS FCFALMKT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M -20M

2.3 Liquidity

A Current Ratio of 0.27 indicates that ALMKT may have some problems paying its short term obligations.
With a Current ratio value of 0.27, ALMKT is not doing good in the industry: 92.98% of the companies in the same industry are doing better.
A Quick Ratio of 0.14 indicates that ALMKT may have some problems paying its short term obligations.
ALMKT's Quick ratio of 0.14 is on the low side compared to the rest of the industry. ALMKT is outperformed by 92.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.14
ALMKT.PA Yearly Current Assets VS Current LiabilitesALMKT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

5

3. Growth

3.1 Past

The earnings per share for ALMKT have decreased strongly by -114.81% in the last year.
The Revenue for ALMKT has decreased by -26.96% in the past year. This is quite bad
ALMKT shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 0.60% yearly.
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.77%
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%3.25%

3.2 Future

Based on estimates for the next years, ALMKT will show a very strong growth in Earnings Per Share. The EPS will grow by 116.79% on average per year.
Based on estimates for the next years, ALMKT will show a very strong growth in Revenue. The Revenue will grow by 35.72% on average per year.
EPS Next Y90%
EPS Next 2Y116.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALMKT.PA Yearly Revenue VS EstimatesALMKT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M
ALMKT.PA Yearly EPS VS EstimatesALMKT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALMKT. In the last year negative earnings were reported.
Also next year ALMKT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALMKT.PA Price Earnings VS Forward Price EarningsALMKT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALMKT.PA Per share dataALMKT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.1 -0.2 -0.3

4.3 Compensation for Growth

ALMKT's earnings are expected to grow with 116.79% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y116.79%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALMKT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

MAUNA KEA TECHNOLOGIES

EPA:ALMKT (9/3/2025, 7:00:00 PM)

0.106

+0 (+1.73%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)04-24 2025-04-24/amc
Earnings (Next)10-02 2025-10-02
Inst Owners16.8%
Inst Owner ChangeN/A
Ins Owners0.98%
Ins Owner ChangeN/A
Market Cap8.41M
Analysts86.67
Price Target0.61 (475.47%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-25%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)81.82%
EPS NY rev (3m)81.82%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.1
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.16
EYN/A
EPS(NY)-0.01
Fwd EYN/A
FCF(TTM)-0.08
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS0.1
BVpS-0.31
TBVpS-0.33
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.04%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.67%
FCFM N/A
ROA(3y)-45.6%
ROA(5y)-50.64%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y39.93%
GM growth 5YN/A
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 10.86%
Cap/Sales 2.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.14
Altman-Z -5.57
F-Score3
WACC6.07%
ROIC/WACCN/A
Cap/Depr(3y)16.65%
Cap/Depr(5y)36.4%
Cap/Sales(3y)2.78%
Cap/Sales(5y)7.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.81%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%39.77%
EPS Next Y90%
EPS Next 2Y116.79%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-26.96%
Revenue growth 3Y-0.2%
Revenue growth 5Y0.6%
Sales Q2Q%3.25%
Revenue Next Year32.89%
Revenue Next 2Y35.72%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-594.15%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year41.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-475.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-738.73%
OCF growth 3YN/A
OCF growth 5YN/A